The Maune Raichle Law Firm

International Mesothelioma Program

The international mesothelioma program is a division of thoracic surgery at the Brigham and Women’s hospital in Boston, Massachusetts. It has been credited with many of the most significant advancements in mesothelioma research and treatment. Many of the treatments pioneered by the International Mesothelioma Program are now standard practices in clinics across the country and around the world. To stay on the forefront of mesothelioma treatment, the International Mesothelioma Program continues to serve as leader in both research and treatment.

The approach the International Mesothelioma Program uses is to have a multidisciplinary team comprised of the best possible professionals in various disciplines within the study and research of mesothelioma. Through this synergy of the best doctors, nurses, radiologists, pathologists, surgeons, clinical researchers, and social scientists on staff, the International Mesothelioma Program can not only continue to develop better treatment strategies for the future, but also apply those principles to the patients they treat. In a little over a year, the IMP has already been able to improve the short term survival rates of their patient base. Posting short term survival rates on par with or better than some of the longest running mesothelioma programs worldwide, the IMP proves itself as a quality program.

The main focus of the International Mesothelioma Program is the development of more effective therapies and improving the survival rate of not just their patients, but also all individuals diagnosed with mesothelioma. In research, the IMP looks into the cases of mesothelioma to better understand what type of treatments will be the most effective. In clinical practice, the program’s goal is to improve and refine treatment, increasing long term survival rates as well as patient comfort.